Positive control plasma samples from confirmed COVID-19 patients (BEI resources; n = 4) were positive for antibodies against S-RBD of SARS-CoV-2 with some cross-reactivity to S protein of SARS-CoV (as well as to S proteins from common coronaviruses). This evidence concerns the gene PROS1 and COVID-19.